Trent Middleton served as the defense's first witness, presenting Rule 1006 summaries and calculations from selected Theranos records. Cross-examination addressed defense involvement in preparing the charts and Middleton's lack of personal, technical, or transactional knowledge beyond the compilation work.
Trent Middleton
Williams & Connolly paralegal who prepared defense summaries of Theranos records.
About
Trent Middleton appeared as the defense's first witness and presented Rule 1006 summaries derived from selected Theranos patent, financial, investment, test-menu, and laboratory records.
On direct examination, Middleton explained how he compiled patent information and calculated or counted figures involving customer receipts, option or stock proceeds, investment entries, listed tests, and laboratory volumes. He described his role as counting, sorting, copying, or summing selected data rather than independently investigating the underlying records.
On cross-examination, Middleton acknowledged that Williams & Connolly employed and supervised him, defense attorneys selected the summary subjects and supplied terminology and a template, and other contributors sometimes helped populate shared charts. He said he reviewed contributions for inaccuracies but could not identify every contributor or the template's creator. Middleton also confirmed that he had no personal knowledge of Theranos operations and could not draw substantive conclusions about patent functionality, testing devices, financial entries, investor motives, patient activity, or other matters beyond his calculations.
Trial Record (4)
No proceedings match this filter.